This panel discussion intends to explore the funding sources currently available for early-stage animal health innovations.
What is the role and availability of public funding in animal health innovation? How prevalent is grant financing and what are its principal orientations? How important are the welfare and public health dimensions in this funding?
How attractive are animal health start-ups to venture capital and who are the investors? Is the European early-stage capital market for animal health rich enough in players and capital?